in

FDA Greenlights Imaging Agent to Detect Residual Cancer After Lumpectomy

Source link : https://www.newshealth.biz/health-news/fda-greenlights-imaging-agent-to-detect-residual-cancer-after-lumpectomy/

The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the Lumicell Direct Visualization System (DVS) or another fluorescence imaging device approved for use with pegulicianine. The fluorescent dye is administered intravenously before surgery. Then after the tumor is removed, […]

Author : News Health

Publish date : 2024-04-18 17:02:40

Copyright for syndicated content belongs to the linked Source.

6 Planches à griller pour barbecue en bois de cèdre de taille XL – lot de 6

“It will be difficult Napoli” – Italian football expert speaks on prospect of losing Osimhen